BioWisdom Joins $14.5M European Alzheimer Biomarker Project | GenomeWeb

NEW YORK, May 4 (GenomeWeb News) - Cambridge, UK-based BioWisdom said today that it will join the AddNeuroMed project of the European Commission's Innovative Medicines for Europe consortium, where it will use its Sofia software platform to help identify and validate Alzheimer's disease biomarkers.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.